JP2024511091A5 - - Google Patents

Info

Publication number
JP2024511091A5
JP2024511091A5 JP2023558248A JP2023558248A JP2024511091A5 JP 2024511091 A5 JP2024511091 A5 JP 2024511091A5 JP 2023558248 A JP2023558248 A JP 2023558248A JP 2023558248 A JP2023558248 A JP 2023558248A JP 2024511091 A5 JP2024511091 A5 JP 2024511091A5
Authority
JP
Japan
Prior art keywords
composition according
pharmaceutically acceptable
pharmaceutical product
collapse
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023558248A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024511091A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/021462 external-priority patent/WO2022204228A1/en
Publication of JP2024511091A publication Critical patent/JP2024511091A/ja
Publication of JP2024511091A5 publication Critical patent/JP2024511091A5/ja
Pending legal-status Critical Current

Links

JP2023558248A 2021-03-24 2022-03-23 睡眠時無呼吸を治療するための方法及び組成物 Pending JP2024511091A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163165342P 2021-03-24 2021-03-24
US63/165,342 2021-03-24
PCT/US2022/021462 WO2022204228A1 (en) 2021-03-24 2022-03-23 Methods and compositions for treating sleep apnea

Publications (2)

Publication Number Publication Date
JP2024511091A JP2024511091A (ja) 2024-03-12
JP2024511091A5 true JP2024511091A5 (https=) 2025-04-01

Family

ID=81388916

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023558248A Pending JP2024511091A (ja) 2021-03-24 2022-03-23 睡眠時無呼吸を治療するための方法及び組成物

Country Status (15)

Country Link
US (1) US20240173337A1 (https=)
EP (1) EP4313153A1 (https=)
JP (1) JP2024511091A (https=)
KR (1) KR20230159462A (https=)
CN (1) CN117062626A (https=)
AU (1) AU2022245235A1 (https=)
BR (1) BR112023019256A2 (https=)
CA (1) CA3212035A1 (https=)
CL (1) CL2023002824A1 (https=)
CO (1) CO2023012587A2 (https=)
CR (1) CR20230457A (https=)
GE (1) GEAP202416361A (https=)
IL (1) IL307186A (https=)
MX (1) MX2023011213A (https=)
WO (1) WO2022204228A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250057804A (ko) * 2022-09-02 2025-04-29 애프니메드, 인코포레이티드 (델라웨어) 수면 무호흡증을 치료하기 위한 방법 및 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102874891B1 (ko) * 2018-01-30 2025-10-21 애프니메드, 인코포레이티드 (델라웨어) 수면 무호흡증을 치료하기 위한 방법 및 조성물
CN118557736A (zh) * 2019-02-08 2024-08-30 布里格姆妇女医院 用于治疗睡眠呼吸暂停的方法和组合物
JP2023520455A (ja) * 2020-04-02 2023-05-17 アプニメッド,インコーポレイテッド(デラウェア) 睡眠時無呼吸を治療するための方法および組成物

Similar Documents

Publication Publication Date Title
ES3004544T3 (en) Film formulations containing dexmedetomidine and methods of producing them
JP2023139000A5 (https=)
ES2378255T3 (es) Titulación de tapentadol
JP2008535867A5 (https=)
JP2020517719A5 (https=)
JP2015512406A5 (https=)
JP2009536176A5 (https=)
JP2006506378A5 (https=)
CN101132777A (zh) 用于睡眠障碍的药物组合物
AU2010237120A1 (en) Method for on-demand contraception
CN105431144A (zh) 阿坎酸制剂、使用阿坎酸制剂的方法以及包含阿坎酸制剂的组合
JP2025084754A5 (https=)
JP2022504181A5 (https=)
JP2022519721A5 (https=)
JP2008533127A5 (https=)
JP5362151B2 (ja) Pgd2拮抗剤及びヒスタミン拮抗剤からなるアレルギー性鼻炎治療用医薬
BR112019027286B1 (pt) Composição de dissolução oral de melatonina com agente acidificante que torna melatonina solúvel em saliva
CN100558358C (zh) 唑尼沙胺在制备用于治疗或预防阻塞性睡眠呼吸暂停的药物中的应用
JP2024511091A5 (https=)
CN103957707A (zh) 与女性胃轻瘫有关的症状的治疗
JP2009535409A (ja) 即効性ジクロフェナク−オピオイド組成物に基づく急性疼痛医薬
TW200927118A (en) Treatment of vasomotor symptoms
CN105073098A (zh) 包含选择性孕酮受体调节剂的共微粉化产物
JP2024523876A5 (https=)
JP2024534173A5 (https=)